Hepatocellular carcinoma (HCC) is believed as one of the most common tumours in the digestive system, which ranks the fifth most frequent cancer and the third leading cause of cancer-related death, respectively, all over the world, 1 but is usually diagnosed at the late or advanced stage due to the lack of early diagnosis solution, resulted in a poor prognosis. 
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MicroRNAs (miRNAs) are small non coding RNA molecules, consisting of 19-25 nucleotides (nts), which can regulate gene expressions at the post-transcriptional level by directly degrading mRNA or inhibiting its translation. 6 Several lines of evidence demonstrated that miRNAs, as one of the crucial regulators, could mediate the interaction between the virus and the host. 7, 8 Besides, hepatitis B virus X protein (HBx) is well known as the essential component for HBV replication could induce the abnormal expression of miRNA. For example, HBx was suggested to increase miRNA-29a and miRNA-21, 9, 10 but decrease miR-148, miR-152 and let-7, [11] [12] [13] to be involved in the pathogenesis of HBV-related HCC. In turn, miRNA could also regulate the replication of HBV. For instance, both miR-199a-3p and miR-210
have been found to play important roles in controlling HBV replication in HBV-positive HepG22.2.15 cells. 14 Besides, miR-15a/miR-16-1
was also identified to influence the growth of HCC cells via blocking the replication of HBV. 15 To date, there was evidence indicated that miR-520 family, served as anti-onco-miRNAs, was implicated in regulating the tumorigenesis and development of various solid cancers. 16 To be specific, miR-520b, as a member of miR-520 family, was reduced, while its target gene (HBXIP) was elevated, both of which were mediated by HBx, contributing to hepatocarcinogenesis in vitro and in vivo. 17 Of note, as another member of miR-520 family, miR520e was also reported able to target NF-kappaB-inducing kinase (NIK) to mediate NIK/phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2)/Nuclear factor kappa-B (NF-κB) pathway, and thereby inducing the occurrence of HCC. 18 Hence, we hypothesized that miR-520e may exert functions in HBV-related HCC.
Furthermore, using the target gene prediction website, we found that EphA2 was the target gene of miR-520e, and it could regulate the MAPK signalling pathway in HCC cells, as indicated by
Jin et al. 19 More importantly, HBx has been demonstrated to participate in the development and progression of HBV-related HCC by activating the MAPK signalling pathway. 20 Therefore, this study was undertaken to investigate whether miR-520e could regulate HBV replication and HCC growth by mediating the MAPK signalling pathway through targeting EphA2, hoping to provide new theoretical support for the diagnosis and treatment of HBV-related HCC.
| MATERIAL S AND ME THODS

| Ethics statement
This study was approved by the Ethics Committee of our hospital after discussion, which was in accordance with the ethics standards laid down in the 1964 Declaration of Helsinki, and all patients were informed of the purpose and content of the study and agreed to sign the informed consent.
| Tissue specimens
From October 2016 to October 2017, tumour tissues and adjacent tissues (>2 cm) were collected from 45 HBV-positive HCC patients at the early stage who received hepatic carcinectomy in the Department of Hepatobiliary Surgery in our hospital. There were 32 male and 13 female patients with the age of 53.56 ± 10.45 years old.
All tissue samples were verified by clinical and pathological examinations and then cryopreserved at −80°C. 
| Cell lines and cell culture
| Transfection of HCC cells with stably expressed HBx
Huh7-X cells, HCC cell line with stable expression of HBx, and
HepG2-X cells were established and preserved in advance in the laboratory. To investigate the mechanism of miR-520e downregulation, Huh7-X, HepG2-X and HepG2.2.15 cells were seeded to 6-well plates by 1 × 10 6 cells/well and cell confluence reached 70%-80% on the next day. The transfection was carried out according to the instructions on the LipofectamineTM2000 kit (Invitrogen). Cells were transfected with si-HBx plasmids by 0, 0.5, 1, 1.5 μg in each well, and the expression levels of HBx and miR-520e were detected after 48 hours transfection.
| Dual-luciferase report gene assay
The miRNA target gene prediction software (microRNA.org) was used to predict the binding site of miR-520e and EphA2 3′UTR. We established the wild-type plasmid EphA2 WT and the mutant-type plasmid EphA2 MUT. The transfection was performed by following the instructions using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA). HepG2 cells (purchased from ATCC) were transfected and classified into four groups: miR-520e mimic+ EphA2-WT group, mimic NC+ EphA2-WT group, miR-520e mimics+ EphA2-MUT group and mimic NC+ EphA2-MUT group. After 48 hours transfection, the luciferase activity of each sample (Promega) was detected by dual-luciferase reporter gene assay. The experiment was repeated for three times. 
| Cell grouping and transfection
| Detection of HBV DNA content
The supernatant of each cell sample was collected and detected for HBV DNA with a HBV DNA kit (QIAGEN). Next, HBV DNA copies were quantified by qRT-PCR according to the instructions of the kit.
The reaction conditions included: 40 cycles of 37°C for 5 minutes, 94°C for 2 minutes, 95°C for 5 seconds and 60°C for 40 seconds.
Then, fluorescence signals were collected at 60°C. The results were obtained and analysed to draw a standard curve for each experiment. The experiment was repeated for three times. The mean value of three experiments was regarded as the final result.
| Detection of HBsAg and HBeAg by ELISA
The cell culture medium was collected 48 hours post-transfection and centrifuged for 5 minutes at the rate of 4100 g to obtain the supernatant. Then, the HBsAg and HBeAg viral protein levels were determined by ELISA kits (Shanghai Kehua Bio-Engineering Co., Ltd., Shanghai, China) in the supernatant in line with the instructions, and a microplate reader was used to detect the absorbance value (OD) of each well under the wavelength of 450 nm. The experiment was performed in triplicate.
| Cell proliferation by CCK8 assay
The cell proliferation was detected by CCK8 kits (Dojindo Molecular Technologies, Inc., Kumamoto, Japan). First, cells were inoculated onto the 96-well plate at 10 3 cells/well (200 μL/well) with five duplicates as a set. At the same time, blank control group (only added with medium) was set for 24, 48 and 72 hours of incubation. Next, CCK8 kit was added into each well (by 1:9 in CCK8 to medium) for 1-4 hours of incubation at 37°C. The black control group was used for zero setting, and the absorbance value (OD) of each well under the wavelength of 450 nm was obtained from the microplate reader.
The experiment was repeated for three times, respectively.
| Cell apoptosis by flow cytometry
Annexin V-FITC/PI reagent (Shanghai BogooBiotechnology, Co., Ltd)
was used to detect cell apoptosis. Cells were collected in the logarithmic growth phase, digested by 0.25% trypsin, washed twice with PBS buffer, centrifuged and added with 195 μL binding buffer to suspend cells. Next, 5 μL Annexin V-FITC was added into the cell suspension, which was placed for a while and centrifuged for cell collection. Then, 190 μL binding buffer was added to suspend cells, followed by the addition of 10 μL propidium iodide (PI) for mixing at room temperature and without exposure to light. Cell apoptosis was determined by a flow cytometer, and the experiment was conducted for three times independently. The experiment was performed in triplicate. 
| qRT-PCR
| Western blot
The proteins were extracted and added with loading buffer for 10 minutes of heating at 95°C with 30 μg/well. Next, 10% polyacrylamide gel electrophoresis was used to separate proteins, followed by wet transferring to the PVDF (polyvinylidene difluoride) membrane.
Gene Forward primer 5′-3′
Reverse primer 5′-3′
The Primer sequences for qRT-PCR applied in the current study Then, the membrane was placed in 5% bovine serum albumin (BSA)
for blocking before the addition of primary antibodies for overnight reaction at 4°C at 1:1000 dilution, including EphA2, HBx, p38MAPK, p-p38MAPK, ERK1/2 and p-ERK1/2 (Cell Signaling Technology, Danvers, MA, USA). After that, the membrane was washed with TBST (tris-buffered saline with Tween-20) for 3 times/5 min and corresponding secondary antibodies were added for 1 hour of incubation at room temperature. At last, the membrane was washed for another 3 times/5 min before the chemiluminescent detection. With β-actin as the internal reference, the grey value of target bands was analysed with the software Image J (NIH Image, Bethesda, MD,USA).
The experiment was performed in triplicate.
| Mice model establishment with adenovirusmediated HBV replication
Based on a previous study, 21 6-week-old male C57BL/6 mice were injected with rAAV8-1.3HBV (1 × 10 11 vg/200 μL/mouse) via the tail vein to construct model mice with the chronic HBV infection, which were randomly divided into two groups with 8 mice in each group:
HBV+ miR-520e mimic group and HBV+NC group, which were injected with miR-520e mimic and negative control plasmid, respectively, by the high-pressure hydrodynamic method. Another eight mice without HBV injection were set as the Normal group. Three days after injection, those mice were killed to take their liver tissues and tail vein blood. As described above, the relative expression of miR-520e in liver tissues and HBV DNA copy number in serum were analysed by qRT-PCR.
| Statistical method
All experiments were repeated in three times. All data were analysed by using the statistical software SPSS 21.0 (SPSS, Inc, Chicago, IL), which were presented by mean ± standard deviation (x ± s). For difference between two groups, the data were compared by using the Student's t test, while among multiple groups were tested by oneway ANOVA with Tukey's HSD post hoc test. P < 0.05 believed as the statistical significance.
| RE SULTS
| Expression of miR-520e and EphA2 in HBVpositive tissues and cell lines
The expression of miR-520e and EphA2 in HBV-positive HCC tissues and cell lines was detected by qRT-PCR. The results found that HBVpositive HCC tissues had significantly decreased miR-520e and apparently increased EphA2 compared to normal tissues (all P < 0.05).
In addition, HBV-positive HepG2. Figure 1 ).
| HBx down regulates the expression of miR520e
We constructed the Huh7-X and HepG2-X cell lines in which HBx was stably expressed were established, and we found the significant elevation of HBx protein in Huh7-X and HepG2-X cells (Figure 2A ,B, all P < 0.05). In addition, the miR-520e levels presented to be remarkably lower in Huh7-X and HepG2-X cells than Huh7 and HepG2 cells ( Figure 2C , P < 0.05). To further confirm the down regulation of miR-520e by HBx, we found that the levels of miR-520e were dosedependently enhanced via interfering HBx in a dose-dependent manner in Huh7-X, HepG2-X and HepG2.2.15 cells ( Figure 2D ,E), which suggested that HBx could reduce the expression of miR-520e
( Figure 2F , P < 0.05).
| EphA2 is the target gene of miR-520e
Online miRNA target gene prediction website (http://www. microrna.org) was employed to predict the target gene of miR520e, and we found EphA2 to be one of the target genes of miR-520e ( Figure 3A) . As illustrated by dual-luciferase reporter gene assay, the relative activity of luciferase was remarkably reduced after co transfection with EphA2 3′UTR-WT and miR520e mimic when compared with that of EphA2 3′UTR-WT + miR-520e NC group (P < 0.05). On the other hand, no change in luciferase activity was observed in EphA2 3′UTR -MUT+ miR520e mimic group and EphA2 3′UTR -MUT + miR-520e NC group (all P > 0.05, Figure 3B ), which suggested that EphA2 is the target gene of miR-520e.
| Expression of miR-520e and EphA2 after transfection
After transfection, the expression of miR-520e and EphA2 in 
F I G U R E 3
The relative luciferase activity after co transfection with EphA2 3′UTR and miR-520e mimic. Note: A, Sequence alignments between 3′UTR of EphA2 and miR-520e; B, The relative luciferase activity analysis after co transfection with EphA2 3′UTR and miR-520e mimic (or miR-520e NC); *, P < 0.05 compared with NC group
decreased in EphA2; however, miR-520e inhibitor and miR-520e inhibitor+ si-EphA2 groups exhibited lower levels of miR-520e, and meanwhile, miR-520e inhibitor group was elevated in EphA2 and si-EphA2 group was down regulated in EphA2 (all P < 0.05). Further, miR-520e inhibitor+ si-EphA2 group showed no observable difference in miR-520e expression (P > 0.05), but an obvious reduction in EphA2 protein by comparison with miR-520e inhibitor group (all P < 0.05, Figure 4 ).
| Effect of miR-520e on HBV DNA replication and the levels of HBsAg and HBeAg
As compared with Mock group in both HepG2.2.15 and pHBV1.2 + Huh7 cell lines, miR-520e mimic and si-EphA2 groups were notably reduced, while miR-520e inhibitor group was markedly enhanced in HBV DNA copy number and the levels of HBsAg and HBeAg (all P < 0.05, Figure 5 ), but there was no difference from NC group (all P > 0.05). In addition, miR-520e inhibitor +si-EphA2 group was substantially lower than miR-520e inhibitor group, but higher than si-EphA2 group regarding the HBV DNA copy number, HBsAg expression and HBeAg expression (all P < 0.05).
| Cell proliferation after transfection
As illustrated by Figure 6 , in HepG2.2.15 and pHBV1.2 + Huh7 cell lines, Mock group and NC group were not statistically different from each other in cell proliferation and apoptosis (P > 0.05). Besides, both miR-520e mimic group and si-EphA2 group were significantly reduced in cell proliferation and apparently elevated in cell apoptosis (all P < 0.05), but the miR-520e inhibitor group showed the completely opposite trend in these two indexes (all P < 0.05). Compared with the miR-520e inhibitor group, the miR-520e inhibitor + si-EphA2 group decreased significantly in cell proliferation and increased remarkably in cell apoptosis (all P < 0.05).
| Protein expression of p38MAPK and ERK1/2 pathways
The protein expressions of p38MAPK and ERK1/2 pathways in transfected HepG2.2.15 and pHBV1.2+ Huh7 cells were determined by Western blot ( Figure S1 ). Compared with Mock group, miR-520e mimic and si-EphA2 groups were clearly down regulated, while miR520e inhibitor group apparently up regulated in protein expression of p-p38MAPK/p38MAPK and p-ERK1/2/ERK1/2 pathways (all P < 0.05). Meanwhile, miR-520e inhibitor group was higher in protein expression of p-p38MAPK/p38MAPK and p-ERK1/2/ERK1/2 pathways than the miR-520e inhibitor + si-EphA2 (all P < 0.05).
| Effect of miR-520e on HBV replication and expression in vivo
The levels of miR-520e in liver tissues of HBV-related mice model were detected. According to the results shown in Figure S2 , compared with mice in the Normal group, those in the HBV+NC group had statistically decreased expression of miR-520e and apparently increased expression of EphA2 in liver tissues (all P < 0.05). At the same time, mice in HBV + miR-520e mimic group were higher in miR-520e and lower in EphA2 than those in HBV + NC group (all P < 0.05). On the other hand, mice in HBV + NC group were found to have increased HBV DNA content in serum (all P < 0.05), and specifically, mice in HBV+ miR-520e mimic group had lower serum levels of HBV DNA than those in HBV + NC group (all P < 0.05).
| D ISCUSS I ON
A great number of studies have found the down regulation of miR520e, well documented as a tumour suppressor gene, in a variety of tumour cells, such as breast cancer, 22 gastric cancer 23 and lung cancer. 24 In agreement, this study also discovered a significant re- [38] [39] [40] Notably, HBx has been reported to be the activator of the Src family of tyrosine kinases, which could activate the Ras-Raf-MAPK pathway to affect the proliferation and apoptosis of HBV-related HCC, and at the same time, the activation of Src also enhanced the activity of viral polymerase and thereby promoting HBV replication. 20, 41, 42 As we know, ERK/12 and p38MAPK are two of the most important pathways in MAPK signalling, 43 and a previous study confirmed that EphA2
can regulate p38MAPK and ERK1/2 signalling pathway to affect cell growth. 19 Therefore, we determined the proliferation and apoptosis of HepG2.2.15 and pHBV1.2+ Huh7 cell, as well as the expressions of pathway-related proteins, and found that upregulation of miR-520e
inhibited cell proliferation and blocked p38MAPK and ERK1/2 pathways, whereas inhibiting miR-520e led to completely opposite results, and si-EphA2 reversed the effect of miR-520e inhibitor. Coincidentally, miR-520d-3p, another member of miR-520 family, could target EphA2 to suppress the proliferation, invasion and migration od gastric cancer cells, as indicated by Li et al, 44 and downregulation of EphA2 has been previously shown to inhibit Ras/MAPK pathway to inhibit tumour growth. 45 The above-mentioned findings demonstrated that miR-520e may block the downstream MAPK signalling pathway by targeting EphA2, consequently interrupting the HBV replication and cell proliferation of HBx-mediated HCC. Last but not least, miR-520e can inhibit HBV replication by down regulating EphA2 was also confirmed by animal models in our experiment.
To sum up, miR-520e was found to be down regulated in HBVpositive HCC tissues and cells. Besides, over expression of miR-520e
can specifically inhibit EphA2, thus blocking the p38MAPK and ERK1/2 pathways, further resulted in HBV replication and HCC growth. Hence, this study provided a theoretical basis for the prevention and clinical treatment of HBV-related HCC.
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